Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities CRVS - Corvus Pharmaceuticals, Inc.
15.5 M
LAST VALUE
-15.10%
2 YEAR CAGR
20.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR